Article By:
ChinaBio® Today
Saturday, September 11, 2021 1:30 PM EDT
France's Sanofi will acquire Kadmon Holdings of New York City in a $1.9 billion deal. In 2019, Kadmon formed a JV with BioNova Pharma to develop its novel lead drug, Rezurock (belumosudil) in China.